Yew Bio Pharm Revenue, Profits - YEWB Quarterly Income Statement

Add to My Stocks
$0.29 $0 (0%) YEWB stock closing price Sep 22, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Yew Bio Pharm stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase of $15.6M for 2017-Q2 impacts the YEWB stock. Investors typically check year over year or quarter over quarter revenue growth. The Yew Bio Pharm profit and loss statement for 2017-Q2 shows a profit of $10.26M. Profits have grown from $0.17M QoQ. Apart from this an investor should also check Yew Bio Pharm assets and Yew Bio Pharm free cash flow. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Yew Bio Pharm Net Sales or Revenues
Cost Of Goods Sold (COGS)5.01M7.35M13.24M13.24M14.41M7.22M15.52M3.57M2.28M1.17M
Yew Bio Pharm Gross Profit
Research & Development Expense----------
Selling General & Admin Expense0.29M0.29M0.17M0.29M0.34M0.31M0.46M0.48M0.48M0.47M
Income Before Depreciation Depletion Amortization10.28M0.22M-1.36M1.11M1.3M1.07M1.32M0.93M1.89M0.99M
Depreciation Depletion Amortization----------
Non Operating Income-0.03M-0.05M-0.04M-0.03M--0.02M0.05M-0.11M-
Interest Expense----------
Yew Bio Pharm Pretax Income
Provision for Income Taxes--0.01M----0.04M--0.04M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations10.26M0.17M-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS53.04M56.67M51.88M51.89M51.88M51.88M51.88M52.19M57.62M58.23M
Average Shares used to compute Basic EPS51.88M51.88M51.88M51.88M51.88M51.88M51.88M52.16M52.13M52.13M
Income Before Nonrecurring Items10.26M0.17M-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
Yew Bio Pharm Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.19--
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Yew Bio Pharm stock analysis. An investor must check the following items in an income statement:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that YEWB stock has a topline or revenue of $15.6M for 2017-Q2 as per this Yew Bio Pharm revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YEWB stock had a healthy bottom line growth.
The income statement is also called statement of revenue and expense. The YEWB financials along with Yew Bio Pharm historical stock prices provide a lot of details about the firm .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield